879 results on '"Flipo, René-Marc"'
Search Results
2. Recommandations françaises 2023 pour le diagnostic et la prise en charge des bursites septiques prépatellaires et olécraniennes
3. Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study
4. 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
5. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression
6. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
7. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
8. Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis
9. Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort
10. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
11. Musculoskeletal corticosteroid injections: Recommendations of the French Society for Rheumatology (SFR)
12. COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection
13. Les infiltrations ostéoarticulaires de corticostéroïdes : recommandations de la Société Française de Rhumatologie
14. Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study
15. Interactions médicamenteuses liées à la prescription de rifampicine chez un patient atteint d’un rhumatisme inflammatoire chronique et anti-coagulé
16. Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study
17. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
18. Épidémiologie et écologie des infections ostéoarticulaires bactériennes
19. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis
20. Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases
21. Recommandations de la Société française de rhumatologie sur l’alimentation des patients ayant un rhumatisme inflammatoire chronique
22. Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicentre retrospective observational study.
23. Contribution of Rare Deleterious Variants in Telomere-Related Genes to the Risk of Interstitial Lung Disease in Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis
24. Body Composition in Patients With Psoriatic Arthritis and Changes During Interleukin‐12/Interleukin‐23 Inhibition
25. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
26. Critères d’évaluation à collecter pour optimiser la prise en charge de routine de la spondyloarthrite axiale : proposition fondée sur des preuves et une rencontre d’experts
27. Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
28. 2020 French recommendations on the management of septic arthritis in an adult native joint
29. Recommandations françaises 2020 sur la prise en charge des arthrites septiques sur articulation native de l’adulte
30. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
31. 2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy
32. Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches
33. 2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares
34. Recommandations de la Société française de rhumatologie pour la prise en charge de la goutte : le traitement hypo-uricémiant
35. Recommandations 2020 de la Société française de rhumatologie pour la prise en charge de la goutte : traitement des crises de goutte
36. Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study
37. 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
38. Recommandations pour l’évaluation et l’optimisation de l’adhésion aux traitements de fond médicamenteux des rhumatismes inflammatoires chroniques : un processus basé sur des revues de la littérature et un consensus d’experts
39. Association of axial spondyloarthritis and IgA vasculitis: Report of two cases
40. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus
41. Inertie clinique persistante dans la prise en charge de la goutte en 2014 : étude observationnelle dans une base de données longitudinale française
42. Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent waves
43. Efficacy and management of tocilizumab in polymyalgia rheumatica: results of a multicenter retrospective observational study
44. Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study
45. Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres
46. Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study
47. Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study)
48. Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
49. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers
50. Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.